Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FJFT2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,598
Award facts
- Contract value 100% obligated
- $20,598.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $20,598.16 to DMS Pharmaceutical Group Inc. for Stelara 90 mg/mL syringes on January 16, 2026, with an ultimate completion date of February 9, 2026. This firm fixed-price delivery order carries no set-aside designation and is being performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee under its existing Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award IDC designated SPE2DR, which was established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The IDC, awarded November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, comprising a 30-month base period with three 30-month option periods. The PPV-G GEN V represents part of a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply for Department of Defense military healthcare facilities globally. This delivery order for Stelara, an immunosuppressant biologic, exemplifies the specialized pharmaceutical products DMS Pharmaceutical Group routinely supplies to support DoD medical operations.
Quick answers
Who was awarded contract SPE2DR26FJFT2?
SPE2DR26FJFT2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FJFT2 worth?
The government has obligated $20,598 on SPE2DR26FJFT2.
Is contract SPE2DR26FJFT2 an order under another contract?
Yes. SPE2DR26FJFT2 is a delivery order under SPE2DR25D9157, an indefinite delivery contract.
Was contract SPE2DR26FJFT2 competed?
The extent of competition for SPE2DR26FJFT2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award